🇺🇸 Dihydroergocriptine in United States

Dihydroergocriptine (dihydroergocryptine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Dihydroergocriptine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Hematology approved in United States

Frequently asked questions

Is Dihydroergocriptine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Dihydroergocriptine in United States?

Marketing authorisation holder not available in our data.